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a b s t r a c t
Background and objective: The diagnostic role of serum cytokines depends on the etiology and
pathogenesis of acute appendicitis (AA) and acute mesenteric lymphadenitis (AML). The aim
of this study was to evaluate differences in cytokine levels between AA and AML.
Materials and methods: Data of 7- to 18-year-old children were collected prospectively from
October 2010 to October 2013. There were 31 patients with AA (AA group), 26 with AML (AML
group), and 17 with elective non-inflammatory surgical disease (control group). Serum levels
of IL-10, IL-12(p70), IL-1b, IL-4, IL-6, IL-8, IL-17, MCP-1, EGF, TNF-a and white blood count
(WBC) were measured three times consecutively in each group.
Results: The level of IL-6 and IL-10 was significantly higher in the AA group than the AML
group at the first measurement (8 pg/mL vs. 3.2 pg/mL, P = 0.000; 6.1 pg/mL vs. 3.2 pg/mL,
P = 0.005, respectively). There was a significant difference observed in time dynamics of
concentration of IL-6 and MCP-1 for AA and AML. The area under the curve (AUC) was 0.77
(95% CI 0.64–0.89; P = 0.001) for IL-6 with a cut-off value of 4.3 pg/mL (67.7% sensitivity and
76.9% specificity) for AA 1 h before surgery. The AUC for WBC was 0.72 (95% CI 0.58.4–0.85;
P = 0.005) with a cut-off value of 10.7  103/mL (sensitivity 71.0% and specificity 46.2%).
Conclusions: Serum IL-6 with a cut-off value of 4.3 pg/mL and WBC with a cut-off value of
10.7  103/mL assessed together will yield more sensitivity for AA.
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The right lower quadrant pain is the most common condition
necessitating surgical admission to a pediatric hospital [1,2].
The vast majority of cases are due to either AA or AML in
children [1,3–6]. The incidence of AA is 25 cases per 10,000
pediatric patients per year between the ages of 10 and 17 in the
United States [4,7,8]. 7%–20% of the discharge diagnosis in
pediatric patients with a clinical suspicion of AA was primary
AML [3,9]. Generally, the treatment tactics in both of these
pathologies differ a lot. In the case of AML, treatment is more
conservative and does not require hospitalization [1,3,6,10],
while in the case of AA immediate hospitalization and perhaps
further surgery can be mandatory [7]. Missing the diagnosis of
AA in the emergency department may increase the probability
of perforation of the appendix as well as the rate of other
complications [4,7,8,11]. The rate of perforated appendicitis
has been reported as high as 10%–20% in children 10–17 years
of age [7]. AA and AML in children remain a difficult differential
diagnosis for physicians.
The diagnostic role of some inflammatory variables
depends on the etiology and pathogenesis of AA and AML
[2,4,6]. AA arises from initial luminal obstruction of the
appendix [1,12,13]. This results in local edema secondary to
impaired blood and lymphatic flow. Soon the bacterial barrier
function of the appendicular epithelium fails and bacterial
invasion into the submucosal layers occurs [13]. The presence
of bacteria in these areas results in the activation of immune
defense and local infiltration by T cells, monocytes, and natural
killer cells. Locally interleukins and chemokines are released to
recruit these cells [4,8,14–17]. Cytokines are biological active
substance of polypeptides and glycoproteins with a molecular
weight of 8–30 kDa, which participate in the cellular immunity
in response to specific inflammatory process in the body [14].
We hypothesize that the serum cytokine response of a patient
with AA is different from that of a patient with AML.
The aim of this study was to evaluate the role of serum
cytokines such as interleukin-10 (IL-10), interleukin-12(p70)
(IL-12(p70)), interleukin-1 beta (IL-1b), interleukin-4 (IL-4),
interleukin-6 (IL-6), interleukin-8 (IL-8), interleukin-17 (IL-
17), monocyte chemoattractant protein-1 (MCP-1), epithelial
growth factor (EGF), and tumor necrosis factor-a (TNF-a) in
differentiating between AA and AML in children aged between
7 and 18 years.
2. Materials and methods
2.1. Subjects and study design
This study was approved by the local Ethics Review Board of
the University Children's Hospital, Riga, Latvia (No.
40003457128). All of the patients and parents gave their
informed consent to participate in the study. A prospective
case-control study was conducted at Department of Pediatric
Surgery, University Children's Hospital, Riga, Latvia, and
carried out of 74 patients aged between 7 and 18 years from
October 2010 to October 2013 admitted for surgical evaluation
and treatment with a suspicion of AA.Study patients had to meet following inclusion criteria:
children aged between 7 and 18 years hospitalized in the
University Children's Hospital of Latvia, able to obtained
parental or legal guardian written informed consents as
applicable by local laws and regulations, were to be supported
with the evidence of AA in the abdominal ultrasonography
(appendix more than 6 mm diameter and is not compressible)
or the evidence of AML in the abdominal ultrasonography (3
and more enlarged mesenteric lymph nodes, short axis 10 mm
and more), and at least one of the clinical symptom
(abdominal pain, nausea, rebound tenderness, fever
≥37.3 8C, white blood cell (WBC) count >10  103/mL). If the
patient is female of child-bearing potential she had have a
negative pregnancy test. Exclusion criteria were diabetes,
septic shock, severe acute renal and liver impairment and
chronic hepatic impairment, known immunosuppression,
clinical manifestation of intestinal malabsorption, chronic
inflammatory bowel diseases, infections originating from the
female genital tract, a perforation of the upper gastrointestinal
tract, presence of liver and spleen abscess, all pancreatic
processes, gastrostomy, an indwelling peritoneal catheter,
operated abdominal trauma in past, systemic antibacterial
treatment within the previous 7 days, non-steroidal inflam-
matory drug and hormonal treatment within 30 days. To
minimize selection bias all patients meeting the inclusion
criteria were evaluated by 1 of 5 consultant surgeons to
establish eligibility and perform study enrollment.
From the total number of 91 patients who entered the
study, 17 patients were excluded from study 24 h after
randomization due to following reasons: clinically or microbi-
ologically diagnosed infection in 11 patients (acute tonsillo-
pharyngitis in 5 patients, pneumonia in 2, urinary tract
infection in 2, and enterocolitis in 2) and technical problems
in blood sampling and storing in 6 patients. The remaining
57 patients aged 7–18 years were further analyzed and were
divided into 2 groups according to their outcomes and
inclusion and exclusion criteria. The first study group
consisted of 31 patients who were included before the
treatment with the evidence of AA in the abdominal
ultrasonography and were taken to the operating theater for
appendectomy and AA confirmed by intraoperative findings
and pathological examination of the excised appendix (AA
group). All these subjects were undergone conventional open
appendectomy with right lower quadrant incision by the
consultant surgeon. A pathologist blinded to other clinical data
confirmed the diagnosis of AA. Cultures of the peritoneal fluid
during appendectomy were obtained only for the patients with
evidence of gross perforation of appendix. Peritoneal culture
specimens were tested at the local microbiology laboratory.
The second study group was constituted of 26 patients with
AML confirmed by ultrasound examination at the time
of hospitalization and who did not undergo for surgical
intervention (AML group). Abdominal ultrasonography was
performed by the certified radiologist to avoid operator-
dependent differences. All patients were examined using an
ATL HDI 5000 ultrasound system (Philips Medical Systems,
Bothell, Washington, United States).
In order to determine the reference values of serum
cytokines EGF, IL-10, IL-12(p70), IL-1b, IL-4, IL-6, IL-8, IL-17,
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AA group and AML group, there were 17 healthy children (the
control group) prospectively selected for elective non-inflam-
matory surgical disease (control group). All characteristics of
patients and the pre- and postoperative course were recorded
prospectively using standardized assessment sheets filled out
by one of the authors.
2.2. Cytokine measurements
Blood samples for the determination of cytokines were taken
from the patients with AA and patients with elective non-
inflammatory surgical disease three times: 1 h before the
surgical intervention (before the onset of incision), 24 and 72 h
after the surgical treatment. For those with AML, blood
samples also were collected three times: as soon as the
patients had hospital admission (before any treatment was
given), 24 and 72 h after the patient hospitalization. The
peripheral venous blood samples were collected from an
antecubital vein drawn with a sterile syringe, transferred to a
centrifuge tube. The samples were allowed to clot for 20–
30 min at room temperature. Serum was separated by
centrifugation at 4 8C for 20 min at 1600  g. All specimens
were immediately aliquoted, frozen and stored at 808C.
Serum EGF, IL-10, IL-12(p70), IL-17, IL-1b, IL-4, IL-6, IL-8, MCP-1,
TNF-a levels were evaluated by using Milliplex Map kit (Human
Cytokine/Chemokine Magnetic Bead Panel) for Luminex xMAP
Technology (Luminex 200, Luminex Corporation, Austin,
Texas, United States). The minimum detectable levels of all
cytokines for this assay kit were 3.2 pg/mL.
2.3. Statistical analysis
The data were examined for normality of distribution by
the Shapiro–Wilks test. In case of rejection of normality,
nonparametric test was used. Continuous data were
expressed as median with range (25th and 75th percentile).
The Kruskal–Wallis test was used for three group compar-
isons. The concentrations of cytokines in the first serum assay
were compared among all study groups. In case of significance,
individual differences were identified with the Mann–Whitney
U test. Each serum sample of the AA group was compared with
the corresponding sample of the control group. Categorical
variables were analyzed with the chi-square test. A P value of
<0.05 was considered as statistically significant. A receiver
operating characteristic (ROC) curve was constructed to assess
sensitivity and specificity as well as optimal cut points for each
serum cytokine to diagnose AA and AML. The criterion value
indicated the value corresponding with the highest accuracy
(minimal false negative and false positive results). The ROC
curve is the plot of the proportions of true positive vs. true
negative for each value of the study variable. Receiver
operating characteristic (ROC) curves and the related areas
under curve (AUC) were calculated for each cytokine and
represent discriminatory power of the variable. The area of
0.50 represents a variable with no discriminatory capacity, and
the area of 1.00 indicates a perfect discriminator.
Statistical analyses were performed using SPSS Statistics
for Windows version 20.0 package software (SPSS Inc., United
States).3. Results
3.1. Characteristics of subjects
This report is based on 57 patients: 35 (61.4%) boys and 22
(38.6%) girls with the mean age of 12.9 years (SD 3.2).
Abdominal ultrasound was performed before any treatment
for all patients enrolled in the study. Enlarged abdominal
lymph nodes were detected simultaneously with the inflamed
appendix in three study subjects. Appendectomy was per-
formed and phlegmonous inflammation of appendix was
confirmed, therefore, none of them was excluded from the
study. After the structured histopathological examination of
31 excised appendixes, 10 patients had complicated (gangre-
nous or perforated) AA and 21 had uncomplicated (acute or
phlegmonous) AA. Of these 57 patients, 9 peritoneal cultures
were obtained and 6 of them were positive. Escherichia coli,
Bacteroides, Pseudomonas, Clostridia, Enterococci, Streptococcus and
Staphylococcus were isolated from all specimens (data not
shown). During abdominal ultrasound, 26 patients with AML
were identified with mesenteric lymph nodes spans ≥10 mm,
as it was also one of the inclusion criteria and were received
conservative treatment. The comparison of demographic and
clinical features of the study subjects is shown in Table 1. It can
be clearly seen that on average nausea and vomiting in AML
group was observed by 36 percentage points less often than in
AA group. There were no difference between diagnostic values
by groups such as WBC, C reactive protein (CRP), absolute
neutrophil count (ANC) and duration of symptoms.
The control group consisted of 17 healthy children: 9 (52.9%)
boys and 8 (47.1%) girls with the mean age of 13.2 (SD 3.54).
They underwent laparoscopic ovarian cystectomy, varicocel-
ectomy, open umbilical and inguinal hernia repair and
circumcision procedure with the mean WBC count 6.3
(1 SD)  103/mL.
3.2. Analysis of the cytokine measurements
The values of cytokines IL-10, IL-12(p70), IL-1b, IL-4, IL-6, IL-8,
IL-17, MCP-1, EGF, TNF-a obtained in the AA group one hour
before the operation and in the AML group on the day of
patient admission to hospital are presented with the reference
values of the control group in Table 2. The serum levels of IL-6
and IL-10 significantly increased in the AA group one hour
before the surgical intervention compared to the correspond-
ing values in the AML group on the day of patient admission to
hospital (IL-6(1): z = 3.72; P = 0.0002; IL-10(1): z = 2.81;
P = 0.005). For the AA group, the concentration of serum IL-6
and IL-10 was statistically significantly higher in comparison
to those in AML patients at the first measurement (8 pg/mL vs.
3.2 pg/mL, P = 0.000; and 6.1 pg/mL vs. 3.2 pg/mL, P = 0.005,
respectively).
A more detailed analysis revealed that there was a
statistically significant difference observed between the AA
and control groups within all three measurements in terms of
the following cytokines concentration as IL-10 and IL-6: 8 pg/
mL vs. 3.2 pg/mL (P = 0.02) for IL-6(1); 9.3 pg/mL vs. 3.2 pg/mL
(P = 0.006) for IL-6(2); 3.4 pg/mL vs. 3.2 pg/mL for IL-6(3)
(P = 0.05); 6.1 pg/mL vs. 3.2 pg/mL (P = 0.02) for IL-10(1);
Table 1 – Characteristics of the study patients with AA and AML.
Characteristic Acute appendicitis Acute mesenteric lymphadenitis P value
(AA group) (AML group)
(n = 31) (n = 26)
Age, mean (SD), years 13.4 (2.5) 11.0 (2.4) NS
Gender, male, n (%) 18 (58.1) 17 (65.4) NS
Nausea, n (%) 21 (67.7) 8 (30.8) 0.01
Vomiting, n (%) 16 (51.6) 4 (15.4) 0.01
Duration of symptoms, h 20 (7.0–29.0) 42 (11.9–54.0) NS
Temperature ≥37.3 8C, n (%) 22 (71.0) 15 (57.7) NS
Rebound tenderness, n (%) 31 (100.0) 25 (96.2) NS
WBC, 103/mL 11.1 (8.6–17.9) 9.6 (8.4–12.8) NS
CRP, mg/L 12.3 (3.1–45.5) 7.4 (6.2–10.4) NS
ANC, 103/mL 8.7 (6.2–15.4) 15.9 (6.3–31.5) NS
Values are expressed as median (range) unless otherwise stated. NS, not significant; WBC, white blood cell count; CRP, C reactive protein; ANC,
absolute neutrophil count.
Categorical data were compared by the Chi-square test and continuous data, by the Mann–Whitney test.




AA (n = 31) AML (n = 26) Control group (n = 17) Kruskal–Wallis
test, P value
Median Range Median Range Median Range
EGF 108.7 41.1–108.7 106.8 46.5–152.7 87 38.3–133.6 NS
IL-10 6.1 3.2–17.0 3.2 3.2–3.2 3.2 3.2–3.2 0.005
IL-12(p70) 3.2 3.2–4.9 3.2 3.2–3.2 3.2 3.2–3.5 NS
IL-17 5.9 3.2–38.0 3.3 3.2–9.1 5.8 3.2–29.5 NS
IL-1b 3.2 3.2–3.2 3.2 3.2–3.2 3.2 3.2–8.6 NS
IL-4 3.2 3.2–3.3 3.2 3.2–3.7 3.2 3.2–3.2 NS
IL-6 8 3.2–97.6 3.2 3.2–3.2 3.2 3.2–11.7 0.000
IL-8 15.1 5.7–53.8 10.6 7.0–19.2 18.3 7.1–55.3 NS
MCP-1 411.1 254.6–811.1 333.9 266.0–378.2 352.9 235.8–520.7 NS
TNF-a 12.8 10.0–19.2 14.2 11.0–19.0 12.4 9.9–13.4 NS
NS, no significant difference; AA, acute appendicitis; AML, acute mesenteric lymphadenitis.
m e d i c i n a 5 2 ( 2 0 1 6 ) 2 9 1 – 2 9 72944.0 pg/mL vs. 3.2 pg/mL (P = 0.000) for IL-10(2); 3.6 pg/mL vs.
3.2 pg/mL (P = 0.000) for IL-10(3).
For the patients included in this study, some cytokines
were found to undergo significant changes over the period of
time within the same study group. There was a statistically
significant difference observed in time dynamics of cytokine
serum concentration of IL-6 and MCP-1 for AA patients from
1 h before surgery to 72 h after surgery (Wilks' Lambda test
0.80; F(2, 29) = 3.5; P = 0.04).
There was a statistically significant difference observed in
AML patients in the case of MCP-1 serum concentrations of
cytokines from admission to hospital to 72 h after conservative
treatment (Wilks' Lambda test 0.70; F(2, 24) = 5.0; P = 0.01).
The serum concentration of IL-12(p70), IL-1b, IL-4, TNF-a,
EGF, IL-8 and MCP-1 did not differ significantly between the AA
group and AML group.
Diagnostic cut-off levels for cytokines IL-10, IL-12(p70),
IL-1b, IL-4, IL-8, IL-17, MCP-1, EGF, TNF-a with the low
sensitivity and specificity derived from the area under the
ROC curve (AUC) were 0.40–0.60 in the AA and AML group. In
fact, the significant discriminator power of IL-6 for AA
preoperatively and 24 h after operation was determined by
ROC analysis. AUC was 0.77 (95% CI, 0.64–0.89) for IL-6 with the
cut-off value of 4.3 pg/mL showed 67.7% sensitivity and 76.9%specificity for AA (P = 0.001) 1 h before the operation. AUC for
WBC was 0.72 (95% CI, 0.58–0.85; P = 0.005) with cutoff value
10.7  103/mL (sensitivity 71.0% and specificity 46.2%). The
results of comparisons of the AUC for the WBC and preopera-
tive IL-6 in the AA group were summarized in Fig. 1.
AUC was 0.78 (95% CI 0.66–0.90) for the repeated measure-
ment of IL-6 with the cut-off value of 6.1 pg/mL 24 h after the
operation, showing 54.8% sensitivity and 96.2% specificity for
AA (P = 0.000) (Fig. 2).
4. Discussion
Patients with AML typically have a history of fever and
abdominal pain, frequently with localization in the right lower
quadrant [1,3,5,9,10]. The clinical presentation is similar to
acute AA [4,6,8,10]. A few data are available on the incidence of
this syndrome, and it may vary with the geographic location.
Within one series of hospitalized patients, 50 out of 651 (7.7%)
admitted with the diagnosis of AA had a discharge diagnosis of
AML [5].
In most cases, the gut bacteria have a possible role in
causing common clinical symptoms of the both mentioned
diseases. The bacteriological studies of nonspecific AA, using
Fig. 1 – ROC curve for IL-6(1) level and WBC preoperatively in
the AA group.
Fig. 2 – ROC curve for IL-6(2) level in the AA group 24 h after
surgery.
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anaerobic and aerobic bacteria [13,17,18]. According to
Khanna, in nonspecific AML organisms isolated in culture
include E. coli, Bacteroides, Clostridia species, Enterococci, beta-
haemolytic Streptococcus, Staphylococcus aureus and Yersinia [6].
The present study also revealed that these microbes and
Pseudomonas were isolated from some specimens of the
patients with AA. The character of bacteria was a major factor
in determining their arrest in lymph nodes [5,6]. Therefore, it is
possible that different cytokines could appear in blood of the
patients with AML. According to the above mentioned
statement, Li Bingyun and his co-workers found that S. aureus
infection was reduced by local MCP-1 therapy which is
essential for monocyte and macrophage recruitment in the
first 48 h at the site of infection [19]. In our study we noticed
that there was a significant difference in time dynamics ofserum levels of MCP-1 for AA patients and also for AML
patients. In fact, using the analysis of ROC curves for MCP-1
cut-off values in discriminating between AML and AA, the AUC
was 0.40–0.60 for initial and repeated measurements. There-
fore, it could not be a helpful serum biomarker to distinguish
the patients with AA and AML. However, further studies and
additional statistical analysis are needed to estimate whether
MCP-1 can predict AML on patients' admission to the hospital.
Several previous studies examining the immunologic
response to enteric bacteria within the intestinal lumen have
shown specific cytokine production by certain bacteria which
help in the diagnosis of AA [17]. Two important immunoregu-
latory cytokines produced by cells of the innate defence
system in response to bacteria are IL-12(p70) and IL-10. IL-12
(p70) stimulates interferon-gamma (IFN-g) production from T
cells and natural killer (NK) cells, and increases their
cytotoxicity [15]. Although, IL-10 level was demonstrated to
be significantly higher in serum obtained in the AA group
initially within 20 h after the patient felt ill than of the patients
in the AML group. It could be explained by the study report of
Rivera-Chavez et al., in which IL-6 and IL-10 were found in high
concentration in the serum of patients with uncomplicated
AA, while the proinflammatory ones (IL-1b, IL-12(p70), TNF-a)
were found in low concentration [20]. Manuzak et al. reported
that cytokine profiles in whole peripheral blood mononuclear
cells differed depending on the stimulating bacterial species:
Bacteroides fragilis induced significantly more production of IL-
12(p70) and interleukin-23 than E. coli and Enterococcus,
although E. coli and Enterococcus induced levels of IL-10 that
were significantly higher than the level induced by B. fragile
[16]. These findings reveal that IL-10 and IL-12(p70) could be
the important diagnostic serum markers for AA as a result of
implication of commensal enteric bacteria. It should be
emphasized that we only found a significantly increased
secretion of IL-10 and IL-6 1 h before the surgical intervention
in the cases of AA compared to the corresponding values on
the day of patient admission to hospital with AML. Moreover, it
might be that AA and AML are the result of implication of
enteric bacteria.
IL-6 has a broad range of activity on multiple cells types and
it induces a wide array of responses [21]. One of these is the
acute phase response followed by bacterial endotoxemia
[8,22]. Brănescu et al. found preoperatively that IL-6 in serum
exceeded the maximum value of 9.7 pg/mL in 93.7% of the
study subjects with phlegmonous inflammation of appendix
[22]. This reasoning is consistent with our data finding that
preoperatively concentration of IL-6 was significantly higher
(8.0 pg/mL) in patients with AA as compared to its concentra-
tion (3.2 pg/mL) on the day of patient admission to hospital in
the AML group. In our study ROC analysis revealed that AUC
was 0.77 for IL-6 with the cut-off value of 4.3 pg/mL 1 h before
the operation for AA with a sensitivity of 67.7% and a
specificity of 76.9% (P = 0.001) in discriminating between AA
and AML. It showed that less false positive rate would appear
using IL-6 concentration (equal or more than 4.3 pg/mL)
individually as a diagnostic parameter for AA. The same
picture is presented by the WBC concentration in blood with
cut-off value ≥10.7  103/mL one hour before the operation for
AA, reflecting the AUC value of 72% in ROC analysis, sensitivity
of 74.2% and specificity of 53.8%. Having compared the
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the cases of AA and AML, one must conclude that IL-6 is more
specific for the diagnostics of AA than WBC because it reduces
the possibility of false-positive case detection. Therefore, our
study results do not support the use of IL-6 measurement
alone as a substitute for clinical, routine laboratory and
radiological examinations in patients with suspicion for AA.
The similar results showed by Gűrleyik et al., where the
measurement of IL-6 concentration was not of benefit in
increasing the accuracy of diagnosis of AA because the false
positive rate of the test was 54% in normal appendectomy
cases, and the false negative rate was 19% in patients with
non-perforated AA [23].
Another point of discussion of our study results is IL-6 a
significant difference between the levels of cytokine in the
cases of AA 1 h before the surgical intervention and 72 h after
the operation. Sakamoto and colleagues revealed that serum
IL-6 levels reached maximum within the first postoperative
day and decreased thereafter. That phenomenon is explained
by surgical trauma where IL-6 is produced in the operative field
and enters the peripheral blood stream to induce the elevation
of serum IL-6 [24]. The importance of studying serum
inflammatory markers in AA and AML, could be helpful to
differentiate the stage of inflammation because most patients
are healthy before developing AA and AML, and the length of
symptoms before hospitalization is typically less than 48 h
[20].
One of the main factors hindering or limiting the study is
related to the sample presentation or, in other words, the
inclusion of appropriate number of cases according to the
studied frequency of disease pathology. A total of 91 patients
was analyzed in the study USG examination of abdominal
organs was necessary for 74 patients, but 74 patients needed a
full cytokine analysis. One of the limiting factors for patient
inclusion in the study was the lack of accessibility to the
abdominal ultrasound in the examination period from eight
o'clock in the evening until eight o'clock in the morning. The
second factor was related to get venous blood samples for
cytokine determination during the work day, from eight in the
morning until five o'clock in the afternoon, as during the rest of
the hours and weekends it was impossible to adequately
prepare and store collected blood samples according to the
study protocol due to the high workload of the central
laboratory of the Children's University Hospital of Latvia. At
the onset of the study it was observed that most of the samples
were unfit for further analysis because of blood haemolysis
and elevated storage temperatures of refrigeration equipment.
Therefore, subsequent blood samples were collected in
originally specified working hours.
Another key limiting factor that should be mentioned was
the possibilities for patient follow-up after acute treatment
period. In this study, the group of AML patients was not invited
to the follow-up visits after being discharged from the hospital
to completely exclude any AA case possibility in that period of
time. Consequently, it is difficult to draw any conclusions
about AML as of an isolated disease for all AML patients.
However, referring to a similar study in the Netherlands,
where they compared AA and AML patients; having AML
patients additionally invited for a check-up 3 years later after
their discharge from the hospital, it was observed that 91.4% ofthe cases confirmed diagnosis of AML, while the remaining
cases documented recurrent abdominal pain without any
treatment to be prescribed [10]. Taking into account the
abovementioned study results, we can propose that no
changes in the AML group would be identified by our study
either. In future, the study population should be increased and
the additional analysis of clinical parameters should be done.
5. Conclusions
Serum IL-6 with the cut-off value of 4.3 pg/mL and WBC with
cut-off value of 10.7  103/mL assessed altogether will yield
more sensitivity for AA and could be useful diagnostic markers
to differentiate AA from AML.
Conflict of interest
The authors declare no conflicts of interests.
Acknowledgements
The study was financially supported by a Grant No. 2009/0147/
1DP/1.1.2.1.2/09/IPIA/VIAA/009 from the project Support for
Doctoral and Post-doctoral Investigations Riga Stradiņš Uni-
versity fellowship and a Grant No. 2010.10-4/VPP-4 of the
framework of the Latvian National Program and also by The
national Research program project Biomedicine for public
health (BIOMEDICINE) No 6.1 ‘‘Research on acute and chronic
diseases in a wide age-range children to develop diagnostic
and therapeutic algorithms to reduce mortality, prolong
survival and improve quality of life’’.
r e f e r e n c e s
[1] Hayes R. Abdominal pain: general imaging strategies. Eur
Radiol 2004;14:123–37.
[2] Türkyilmaz Z, Sönmez K, Karabulut R, Elbeğ Ş, Moralioğlu S,
Demirtola A, et al. Sequential cytokine levels in the
diagnosis of appendicitis. Scand J Clin Lab Invest
2006;66:723–32.
[3] Macari M, Hines J, Balthazar E, Megibow A. Mesenteric
adenitis: CT diagnosis of primary versus secondary causes,
incidence, and clinical significance in pediatric and adult
patients. AJR 2002;178:853–8.
[4] Yoon DY, Chu J, Chandler C, Hiyama S, Thompson JE,
Hines OJ. Human cytokine levels in nonperforated versus
perforated appendicitis: molecular serum markers for
extent of disease? Am Surg 2002;68(12):1033–7.
[5] Mandell GL, Bennett JE, Dolin R. Mesenteric adenitis. In:
Mandell GL, editor. Mandell, Douglas and Bennett's
principles and practice of infectious diseases. 7th ed.
Philadelphia: WB Saunders; 2009. 978 pp.
[6] Khanna SK, Jain SK. Staphylococcal suppurative mesenteric
lymphadenitis. Postgrad Med J 1983;59:191–3.
[7] Wray CJ, Kao LS, Millas SG, Millas SG, Tsao K, Ko TC. Acute
appendicitis: controversies in diagnosis and management.
Curr Probl Surg 2013;50:54–86.
m e d i c i n a 5 2 ( 2 0 1 6 ) 2 9 1 – 2 9 7 297[8] Saliakellis E, Thapar N. Paediatric GI emergencies. Best
Pract Res Clin Gastroenterol 2013;27:799–817.
[9] Sicorska-Wiśneiewska G, Liberek A, Góra-Gebka M, Bako W,
Marek A, Szlagatys-Sidorkiewicz A, et al. Mesenteric
lymphadenopathy – a valid health problem in children. Med
Wieku Rozwoj 2006;10(2):453–62.
[10] Toorenvliet B, Vellekoop A, Bakker R, Wiersma F, Mertens B,
Merkus J. Clinical differentiation between acute
appendicitis and acute mesenteric lymphadenitis in
children. Eur J Pediatr Surg 2011;21:120–3.
[11] Chang YJ, Chao HC, Kong MS, Hsia S-H, Yan DC.
Misdiagnosed acute appendicitis in children in emergency
department. Chang Gung Med J 2010;33(9):551–6.
[12] Tsuji M, McMahon G, Reen D, Puri P. New insights into the
pathogenesis of appendicitis based on
immunocytochemical analysis of early immune response.
J Pediatr Surg 1990;25(4):449–52.
[13] Lamps LW. Beyond acute inflammation: review of
appendicitis and infections of appendix. Diagn Histopathol
2008;14(2):68–77.
[14] Dala I, Somekh E, Ilker-Reich A, Boaz M, Gorenstein A,
Serour F. Serum and peritoneal inflammatory mediators in
children with suspected acute appendicitis. Arch Surg
2005;140(2):169–73.
[15] Hessle C, Hanson Å, Wold AE. Lactobacilli from human
gastrointestinal mucosa are strong stimulators of IL-12
production. Clin Exp Immunol 1999;116:276–82.
[16] Manuzak J, Dilon S, Wilson C. Differential interleukin-10
(IL-10) and IL-23 production by human blood monocytesand dendritic cells in response to commensal enteric
bacteria. Clin Vaccine Immunol 2012;19(8):1207–17.
[17] Arlt A, Bharti R, Ilves I, Häsler R, Miettinen P, Paajanen H.
Characteristic changes in microbial community
composition and expression of innate immune genes in
acute appendicitis. Innate Immun 2015;21(1):30–41.
[18] Lamps LW. Infectious causes of appendicitis. Infect Dis Clin
North Am 2010;24(4):995–1018.
[19] Li B, Jiang B, Dietz MJ, Smith ES, Clovis NB, Rao K. Evaluation
of local MCP-1 and IL-12 nanocoatings for infection
prevention in open fractures. J Orthop Res 2010;28(1):1–17.
[20] Rivera-Chavez FA, Wheeler H, Lindberg G, Munford RS,
O'Keefe GE. Regional and systemic cytokines responses to
acute inflammation of the vermiform appendix. Ann Surg
2003;237(3):408–16.
[21] Shaheen M, Broxmeyer HE. The humoral regulation of
hematopoiesis. In: Hoffman R, Benz EJ, Shattil SJ, editors.
Hematology: basic principles and practice. 5th ed.
Philadelphia: Elsevier Churchill Livingston; 2009. 253 pp.
[22] Brănescu C, Şerban D, Dascălu AM, Oprescu SM, Şavlovschi
C. Interleukin 6 and lipopolysaccharide binding protein –
markers of inflammation in acute appendicitis. Chirurgia
2013;108(2):206–14.
[23] Gűrleik G, Gűrleik E, Çetinkaya F, Unalmiser S. Serum
interleukin-6 measurement in the diagnosis of acute
appendicitis. ANZ J Surg 2002;72(9):665–7.
[24] Sakamoto K, Hisano S, Kamohara H, Ishiko T, Mita S,
Ogawa M. Changes of interleukin 6 and soluble IL-6 receptor
levels after surgery. Int Congr Ser 2003;1255:135–42.
